CF
TDACW

Cantor Fitzgerald’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Cantor Fitzgerald’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-67,999
Closed -$17K – 600
2025
Q2 		$17K Hold
67,999
– – ﹤0.01% 410
2025
Q1 		$13.6K Buy
+67,999
New +$12K ﹤0.01% 280

Other funds holding TDACW

SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Cantor Fitzgerald's TDACW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q3 2025, closing a stake of 67,999 shares — an estimated $17K sold.

Cantor Fitzgerald first reported a position in TDACW in Q1 2025 and held it in 2 quarters. The position peaked at $17K in Q2 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Translational Development Acquisition Corp Warrants position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 67,999 Translational Development Acquisition Corp Warrants shares in Q3 2025, an estimated $17K.
  • Cantor Fitzgerald first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 2 quarters.
  • Cantor Fitzgerald's Translational Development Acquisition Corp Warrants position peaked at $17K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.